Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis (VRH) in an Oncological Population
The clinical trial, sponsored by the University of Liege, explores the use of virtual reality hypnosis (VRH) as a supportive care intervention for pain management in oncological patients undergoing port-a-cath placement. The study aims to elucidate the neurophysiological mechanisms of dissociation during VRH, potentially positioning VRH as a novel therapeutic tool in oncology. Given the increasing focus on non-pharmacological pain management strategies, successful outcomes could enhance market interest in VRH technologies, particularly in collaboration with industry partners like Oncomfort. The competitive landscape includes other emerging technologies in pain management and psychological interventions, necessitating diligence on existing patents and market positioning. The trial's findings may influence future product development and partnerships in the digital health and therapeutic sectors.
Indication: Cancer
Modality: medical device
Target: Neurophysiological correlates of dissociation and pain modulation through virtual reality hypnosis (VRH).
Sponsor: University of Liege
Source URL: ClinicalTrials.gov
Source updated: May 05, 2022
Ingested: Jun 18, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Neurophysiological correlates of dissociation and pain modulation through virtual reality hypnosis (VRH).
View original source fields
Condition raw: Cancer
Condition normalized: Cancer
Modality raw: medical device
Modality normalized: medical device
Target raw: Neurophysiological correlates of dissociation and pain modulation through virtual reality hypnosis (VRH).
Target normalized: Neurophysiological correlates of dissociation and pain modulation through virtual reality hypnosis (VRH).